ClinicalTrials.Veeva

Menu

Registry in Korea: BioMimeTM Stent, Ultimaster® Stent vs. Xience® Stent (SMARTDESK-MX)

H

Hyeon-Cheol Gwon

Status

Unknown

Conditions

Ischemic Heart Disease

Treatments

Device: BioMimeTM Stent, Ultimaster® Stent

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02986295
2016-04-059

Details and patient eligibility

About

Comparison of safety and long-term effects of BioMimeTM stent and Ultimaster® stent with Xience® stent

Full description

A prospective, open, multicenter, and observational study will register and compare Xience® groups treated in institutions such as the BioMime ™, Ultimaster® group prospectively registered from June 2016.

The Xience® group has already been registered in the previous study (SMARTDESK-BX), so BioMimeTM and Ultimaster® only need to be registered. Follow-up will be conducted until December 2019, and e-CRF will be completed by April 2020.

Enrollment

2,000 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. 19 years old or older
  2. Clinical evidence of coronary artery disease including asymptomatic ischemia, stable angina pectoris, acute coronary syndrome (unstable angina, non-ST segment elevation myocardial infarction, ST segment elevation myocardial infarction).
  3. Vessel diameter 2.25 ~ 3.5mm, stenosis more than 50% (However, the number of blood vessels, the number of lesions, and the lesion length are not limited)
  4. Voluntary written consent to participate in the trial

Exclusion criteria

  1. Within 24 hours before percutaneous coronary intervention, hemodynamic instability or cardiogenic shock
  2. Life expectancy within 2 years

Trial design

2,000 participants in 2 patient groups

BioMimeTM Stent
Description:
No intervention / Ischemic heart disease with percutaneous coronary intervention with BioMimeTM Stent
Treatment:
Device: BioMimeTM Stent, Ultimaster® Stent
Ultimaster® Stent
Description:
No intervention / Ischemic heart disease with percutaneous coronary intervention with Ultimaster® stent
Treatment:
Device: BioMimeTM Stent, Ultimaster® Stent

Trial contacts and locations

1

Loading...

Central trial contact

Taek Kyu Park; Hyeon Cheol Gwon

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems